Why Molecular Subphenotyping Is Needed in Cardiogenic Shock, and How to Accomplish This?
Am J Respir Crit Care Med
.
2025 Jan 13.
doi: 10.1164/rccm.202407-1475VP.
Online ahead of print.
Authors
Sabri Soussi
1
2
,
Susanna Price
3
4
,
Alastair Proudfoot
5
6
,
Alexandre Mebazaa
7
8
,
Patrick R Lawler
9
10
Affiliations
1
University Health Network, Department of Anesthesiology and Pain Medicine, Toronto, Ontario, Canada.
2
INSERM, UMR-S 942, Cardiovascular Markers in Stress Conditions (MASCOT), Paris, Île-de-France, France; sabri.soussi@uhn.ca.
3
Imperial College London, National Heart and Lung Institute, London, United Kingdom of Great Britain and Northern Ireland.
4
Royal Brompton Hospital, Division of Heart, Lung and Critical Care, London, United Kingdom of Great Britain and Northern Ireland.
5
Queen Mary University of London, Critical Care and Perioperative Medicine Group, London, United Kingdom of Great Britain and Northern Ireland.
6
St Bartholomew's Hospital, Department of Perioperative Medicine, London, United Kingdom of Great Britain and Northern Ireland.
7
Hospital Group Saint-Louis Lariboisiere and Fernand-Widal, Department of Anaesthesiology and Critical Care, Paris, Île-de-France, France.
8
INSERM, UMR-S 942, Cardiovascular Markers in Stress Conditions (MASCOT), Paris, Île-de-France, France.
9
McGill University Health Centre, Montreal, Quebec, Canada.
10
University of Toronto, Toronto, Ontario, Canada.
PMID:
39805090
DOI:
10.1164/rccm.202407-1475VP
No abstract available
Keywords:
Cardiogenic shock; Precision medicine; Subphenotypes.